Letter to the Editor: Anamorelin-Induced QT Prolongation

J Palliat Med. 2023 Apr;26(4):460-461. doi: 10.1089/jpm.2023.0021.

Authors

Yutaka Shimizu¹, Takeo Yasu², Katsura Orimoto³, Naohiro Yabuki¹

Affiliations

¹ Department of Pharmacy, Sainokuni Higashiomiya Medical Center, Saitama, Japan.
² Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Tokyo, Japan.
³ Department of Pharmacy, Asakusa Hospital, Tokyo, Japan.

PMID: 37011296
DOI: 10.1089/jpm.2023.0021

No abstract available

Publication types

Letter

MeSH terms

Electrocardiography
Humans
Hydrazines / adverse effects
Long QT Syndrome* / chemically induced
Oligopeptides / adverse effects

Substances

anamorelin
Hydrazines
Oligopeptides